1-4 of 4
Ulrich Krumpelmann
Close
Sort by
Journal Articles

Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?

Clinical Trials & Observations
Christoph Röllig, Michael Kramer, Christoph Schliemann, Jan-Henrik Mikesch, Björn Steffen, Alwin Krämer, Richard Noppeney, Kerstin Schäfer-Eckart, Stefan W. Krause, Mathias Hänel, Regina Herbst, Volker Kunzmann, Hermann Einsele, Edgar Jost, Tim H. Brümmendorf, Sebastian Scholl, Andreas Hochhaus, Andreas Neubauer, Kristina Sohlbach, Lars Fransecky, Martin Kaufmann, Dirk Niemann, Markus Schaich, Norbert Frickhofen, Alexander Kiani, Frank Heits, Ulrich Krümpelmann, Ulrich Kaiser, Johannes Kullmer, Maxi Wass, Friedrich Stölzel, Malte von Bonin, Jan Moritz Middeke, Christian Thiede, Johannes Schetelig, Wolfgang E. Berdel, Gerhard Ehninger, Claudia D. Baldus, Carsten Müller-Tidow, Uwe Platzbecker, Hubert Serve, Martin Bornhäuser
Journal: Blood
Blood (2020) 136 (7): 823–830.
https://doi.org/10.1182/blood.2019004583
Published: 2020
Includes: Supplemental data
Journal Articles

Time from Diagnosis to Treatment Does Not Affect Outcome in Intensively Treated Patients with Newly Diagnosed Acute Myeloid Leukemia

Christoph Röllig, MD MSC, Michael Kramer, M.Sc., Christoph Schliemann, Jan-Henrik Mikesch, MD, Björn Steffen, MD, Alwin Krämer, MD, Tim Sauer, MD, Mathias Hänel, MD, Regina Herbst, MD, Kerstin Schäfer-Eckart, MD, Richard Noppeney, MD, Edgar Jost, MD, Tim H Brümmendorf, MD, Stefan W Krause, MD, Volker Kunzmann, MD PhD, Hermann Einsele, MD, Sebastian Scholl, Andreas Hochhaus, MD, Lars R. Fransecky, MD, Martin Kaufmann, MD, Andreas Neubauer, MD, Dirk Niemann, MD, Markus Schaich, MD, Norbert Frickhofen, MD, Alexander Kiani, Frank Heits, MD, Ulrich Krümpelmann, Ulrich Kaiser, MD, Johannes Kullmer, Maxi Wass, MD, Stefan Klein, MD, Malte Von Bonin, Jan Moritz Middeke, MD, Christian Thiede, MD, Friedrich Stoelzel, MD, Johannes Schetelig, MDMSc, Gerhard Ehninger, MD, Claudia D Baldus, Carsten Müller-Tidow, MD, Uwe Platzbecker, Hubert Serve, MD, Martin Bornhäuser, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 13.
https://doi.org/10.1182/blood-2019-123717
Published: 2019
Journal Articles

Randomized Comparison of Intermediate-Dose Cytarabine Plus Mitoxantrone (IMA) Versus Standard-Dose Cytarabine Plus Daunorubicin (DA) for Induction Therapy in AML Patients >60 Years. Results from the SAL 60+ Trial

Christoph Röllig, MD, Michael Kramer, MSc., Maria Gabrecht, Mathias Hänel, Regina Herbst, MD, Ulrich Kaiser, Norbert Schmitz, MD PhD, Johannes Kullmer, Sebastian Fetscher, Hartmut Link, MDPhD, Luisa Mantovani-Löffler, Ulrich Krümpelmann, Thomas Neuhaus, Frank Heits, Hermann Einsele, Barbara Ritter, Martin Bornhäuser, MD, Johannes Schetelig, MD M. Sc,, Christian Thiede, MD, Brigitte Mohr, Markus Schaich, MD, Uwe Platzbecker, MD, Kerstin Schäfer-Eckart, Alwin Krämer, Wolfgang E Berdel, MD, Hubert Serve, MD, Gerhard Ehninger, MD, Ulrich S. Schuler, MD
Journal: Blood
Blood (2015) 126 (23): 222.
https://doi.org/10.1182/blood.V126.23.222.222
Published: 2015
Journal Articles

Comprehensive Risk Factor Analysis in 939 Adults with Acute Myeloid Leukemia Receiving Risk Stratified Post-Remission Therapy: Results of the Prospective Randomized AML96 Trial of the German Study Initiative Leukemia (DSIL).

Gerhard Ehninger, Martin Bornhaeuser, Christian Thiede, Walter E. Aulitzky, Heinrich Bodenstein, Bernd Dorken, Hermann Einsele, Martin Gramatzki, Mathias Hanel, Gisela Helm, Anthony D. Ho, Andreas Jakob, Ulrich Krumpelmann, Lothar Leimer, Hartmut Link, Stefan Mahlmann, Andreas Neubauer, Karl-Heinz Pfluger, Mathias Sandmann, Kerstin Schafer-Eckart, Norbert Schmitz, Ulrich S. Schuler, Silke Soucek, Reingard Stuhlmann, Hans-Joachim Tischler, Thomas Wagner, Hannes Wandt, Thomas Illmer, Markus A. Schaich
Journal: Blood
Blood (2007) 110 (11): 1847.
https://doi.org/10.1182/blood.V110.11.1847.1847
Published: 2007